ACTRCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。ACTR遺伝子サイレンサーは、ACTR CRISPR/Cas9ノックアウトプラスミドとACTRDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のACTRCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
ACTR CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ACTR-I CRISPR/Cas9 KOプラスミド (h2) | sc-401283-KO-2 | h | Gene Knockout | GFP | 1 | ||
ACTR-I HDRプラスミド (h2) | sc-401283-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
ACTR-I Double Nickaseプラスミド (h) | sc-401283-NIC | h | Gene Knockout | Puromycin | 1 | ||
ACTR-I Double Nickaseプラスミド (h2) | sc-401283-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
ACTR-I CRISPR/Cas9 KOプラスミド (m) | sc-418974 | m | Gene Knockout | GFP | 0 | ||
ACTR-I Double Nickaseプラスミド (m) | sc-418974-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACTR-I Double Nickaseプラスミド (m2) | sc-418974-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IB CRISPR/Cas9 KOプラスミド (h) | sc-401943 | h | Gene Knockout | GFP | 0 | ||
ACTR-IB HDRプラスミド (h) | sc-401943-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ACTR-IB Double Nickaseプラスミド (h) | sc-401943-NIC | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IB Double Nickaseプラスミド (h2) | sc-401943-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IB CRISPR/Cas9 KOプラスミド (m) | sc-418975 | m | Gene Knockout | GFP | 0 | ||
ACTR-IB Double Nickaseプラスミド (m) | sc-418975-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IB Double Nickaseプラスミド (m2) | sc-418975-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IC CRISPR/Cas9 KOプラスミド (h) | sc-402173 | h | Gene Knockout | GFP | 0 | ||
ACTR-IC HDRプラスミド (h) | sc-402173-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ACTR-IC Double Nickaseプラスミド (h) | sc-402173-NIC | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IC Double Nickaseプラスミド (h2) | sc-402173-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IC CRISPR/Cas9 KOプラスミド (m) | sc-435327 | m | Gene Knockout | GFP | 0 | ||
ACTR-IC HDRプラスミド (m) | sc-435327-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ACTR-IC Double Nickaseプラスミド (m) | sc-435327-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IC Double Nickaseプラスミド (m2) | sc-435327-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IIA CRISPR/Cas9 KOプラスミド (h2) | sc-402524-KO-2 | h | Gene Knockout | GFP | 0 | ||
ACTR-IIA HDRプラスミド (h2) | sc-402524-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
ACTR-IIA Double Nickaseプラスミド (h) | sc-402524-NIC | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IIA Double Nickaseプラスミド (h2) | sc-402524-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IIA CRISPR/Cas9 KOプラスミド (m) | sc-418976 | m | Gene Knockout | GFP | 0 | ||
ACTR-IIA Double Nickaseプラスミド (m) | sc-418976-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IIA Double Nickaseプラスミド (m2) | sc-418976-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IIB CRISPR/Cas9 KOプラスミド (h) | sc-401414 | h | Gene Knockout | GFP | 0 | ||
ACTR-IIB HDRプラスミド (h) | sc-401414-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ACTR-IIB Double Nickaseプラスミド (h) | sc-401414-NIC | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IIB Double Nickaseプラスミド (h2) | sc-401414-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ACTR-IIB Double Nickaseプラスミド (m) | sc-418977-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACTR-IIB Double Nickaseプラスミド (m2) | sc-418977-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ACTR CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ACTR-I CRISPR Activationプラスミド (h) | sc-401283-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACTR-I CRISPR Activationプラスミド (h2) | sc-401283-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACTR-I Lentiviral Activation Particles (h) | sc-401283-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACTR-I Lentiviral Activation Particles (h2) | sc-401283-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACTR-I CRISPR Activationプラスミド (m) | sc-418974-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-I CRISPR Activationプラスミド (m2) | sc-418974-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-I Lentiviral Activation Particles (m) | sc-418974-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-I Lentiviral Activation Particles (m2) | sc-418974-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB CRISPR Activationプラスミド (h) | sc-401943-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB CRISPR Activationプラスミド (h2) | sc-401943-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB Lentiviral Activation Particles (h) | sc-401943-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB Lentiviral Activation Particles (h2) | sc-401943-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB CRISPR Activationプラスミド (m) | sc-418975-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB CRISPR Activationプラスミド (m2) | sc-418975-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB Lentiviral Activation Particles (m) | sc-418975-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IB Lentiviral Activation Particles (m2) | sc-418975-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC CRISPR Activationプラスミド (h) | sc-402173-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC CRISPR Activationプラスミド (h2) | sc-402173-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC Lentiviral Activation Particles (h) | sc-402173-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC Lentiviral Activation Particles (h2) | sc-402173-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC CRISPR Activationプラスミド (m) | sc-435327-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC CRISPR Activationプラスミド (m2) | sc-435327-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC Lentiviral Activation Particles (m) | sc-435327-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IC Lentiviral Activation Particles (m2) | sc-435327-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA CRISPR Activationプラスミド (h) | sc-402524-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA CRISPR Activationプラスミド (h2) | sc-402524-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA Lentiviral Activation Particles (h) | sc-402524-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA Lentiviral Activation Particles (h2) | sc-402524-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA CRISPR Activationプラスミド (m) | sc-418976-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA CRISPR Activationプラスミド (m2) | sc-418976-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA Lentiviral Activation Particles (m) | sc-418976-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIA Lentiviral Activation Particles (m2) | sc-418976-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB CRISPR Activationプラスミド (h) | sc-401414-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB CRISPR Activationプラスミド (h2) | sc-401414-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB Lentiviral Activation Particles (h) | sc-401414-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB Lentiviral Activation Particles (h2) | sc-401414-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB CRISPR Activationプラスミド (m) | sc-418977-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB CRISPR Activationプラスミド (m2) | sc-418977-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB Lentiviral Activation Particles (m) | sc-418977-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACTR-IIB Lentiviral Activation Particles (m2) | sc-418977-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |